Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study-Reference-Cited by-同舟云学术

Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study

Published:2010-02 Issue:2 Volume:21 Page:409-414
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Quaglino P.,Marenco F.,Osella-Abate S.,Cappello N.,Ortoncelli M.,Salomone B.,Fierro M.T.,Savoia P.,Bernengo M.G.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/21/2/409/930250/mdp325.pdf

Reference35 articles.

1. Malignant melanoma and vitiligo-like leukoderma: an electron microscopic study;Koh;J Am Acad Dermatol,1983

2. Cutaneous achromia and malignant melanoma;Barrière;Ann Dermatol Venereol,1984

3. Prognostic significance of hypopigmentation in malignant melanoma;Bystryn;Arch Dermatol,1987

4. Vitiligo and cutaneous melanoma. A case study;Schallreuter;Dermatologica,1991

5. Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells;Cui;Arch Dermatol,1995

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting IL-17A to combat immune-related adverse events;Nature Cancer;2024-08-29

2. CACA guidelines for holistic integrative management of anticancer treatment - induced cutaneous adverse events;Holistic Integrative Oncology;2024-06-28

3. Sarcoid-like reactions to immune checkpoint inhibitors: Incidence, treatment course, and impact on cancer progression and survival;Respiratory Medicine;2024-06

4. The Risk of Keratinocyte Cancer in Vitiligo and the Potential Mechanisms Involved;Journal of Investigative Dermatology;2024-02

5. Systemic Scleroderma Induced by Nivolumab in Malignant Melanoma;In Vivo;2024